RIGHT-SIDED HEART FAILURE
Right-sided heart failure occurs when the right ventricle is unable to pump blood effectively into the pulmonary circulation. As forward flow into the lungs decreases, pressure builds in the systemic venous system, leading to fluid accumulation in the tissues and organs drained by the vena cavae. This produces hallmark features such as peripheral oedema, hepatomegaly, ascites and jugular venous distension. Right-sided failure often develops as a consequence of chronic left-sided failure, but may also arise from intrinsic right ventricular pathology, pulmonary hypertension or chronic lung disease. Its clinical manifestations differ from those of left-sided failure because congestion occurs systemically rather than in the pulmonary circulation.
What You Need to Know
Right-sided heart failure occurs when the right ventricle can no longer pump blood effectively into the pulmonary circulation. The right ventricle is designed as a thin-walled, highly compliant chamber that operates at low pressure, making it well suited to moving blood through the lungs under normal conditions. When pulmonary vascular resistance rises, the right ventricle must generate higher pressures to maintain forward flow. Causes include chronic lung disease, pulmonary hypertension, left-sided heart failure with secondary pulmonary congestion, and acute increases in resistance such as pulmonary embolism. Over time, this pressure overload leads to right ventricular dilation, reduced contractile efficiency, and declining output.
As right ventricular function deteriorates, blood returning to the heart from the systemic circulation cannot be pumped forward efficiently and begins to pool in the venous system. Venous pressures rise, forcing fluid out of the vasculature and into surrounding tissues. The clinical consequences are largely driven by congestion rather than pulmonary oedema, which distinguishes right-sided failure from left-sided disease. Reduced forward flow to the lungs also limits left ventricular preload, contributing to fatigue and reduced exercise tolerance.
The core pathophysiological features include:
Pressure overload of the right ventricle due to increased pulmonary vascular resistance.
Systemic venous congestion from impaired venous return to a failing right heart.
Reduced effective cardiac output from diminished pulmonary and left-sided filling.
Venous congestion has widespread systemic effects. Fluid accumulation in gravity-dependent tissues produces peripheral oedema, most commonly in the ankles and lower legs. Congestion of the liver leads to hepatomegaly and right upper quadrant discomfort, while chronic hepatic venous hypertension may impair liver function over time. Gastrointestinal congestion contributes to abdominal bloating, early satiety, and reduced appetite. Although the initiating problem lies in the right ventricle, the clinical picture reflects multi-organ involvement driven by sustained venous hypertension and reduced forward flow.
Beyond the Basics
Pathophysiological Mechanisms Leading to Right Ventricular Failure
Right-sided heart failure develops when the right ventricle is unable to adapt to sustained increases in workload. The most common pathway is secondary to chronic left-sided heart failure. Persistently elevated left atrial pressure is transmitted backward into the pulmonary circulation, increasing pulmonary venous and arterial pressures. Over time, this creates a chronic pressure load on the right ventricle. This mechanism highlights ventricular interdependence, where dysfunction of one side of the heart progressively impairs the other.
In other cases, right ventricular failure arises from primary right-sided pathology or pulmonary vascular disease. Pulmonary hypertension, whether related to chronic hypoxic lung disease, congenital cardiac shunts, or intrinsic pulmonary vascular disorders, forces the right ventricle to generate pressures well above its normal operating range. The right ventricular wall initially hypertrophies to compensate, increasing muscle mass to generate higher systolic pressures. However, because the right ventricle is not structurally designed for sustained high-pressure work, this adaptation eventually fails. The chamber dilates, wall stress increases, and contractile performance declines.
Acute right ventricular failure represents a distinct scenario. A large pulmonary embolism can abruptly raise pulmonary arterial resistance, overwhelming the right ventricle within minutes to hours. The sudden increase in afterload prevents effective ejection, leading to rapid right ventricular dilation, reduced left ventricular preload, and acute haemodynamic compromise.
Consequences of Reduced Forward Flow Into the Pulmonary Circulation
When right ventricular output falls, blood returning from the systemic circulation cannot be cleared efficiently. Pressure rises within the superior and inferior vena cavae, leading to widespread venous congestion. Unlike left-sided heart failure, where pulmonary symptoms dominate, the clinical impact of right-sided failure is driven primarily by systemic venous hypertension.
The liver is particularly affected because hepatic veins drain directly into the right atrium. Elevated venous pressure causes hepatic sinusoidal congestion, impairing normal metabolic and synthetic function. This congestion often produces right upper quadrant discomfort and hepatomegaly. With chronic exposure, ongoing venous hypertension may lead to fibrosis and congestive hepatopathy.
Venous congestion also affects the gastrointestinal tract. Oedema of the bowel wall reduces effective nutrient absorption and contributes to early satiety, abdominal bloating, and anorexia. Although reduced pulmonary blood flow may mildly impair oxygen uptake, respiratory symptoms are usually less prominent than in left-sided failure unless a primary lung disorder is present.
Fluid Accumulation and Oedema Formation
Sustained elevation of systemic venous pressure increases hydrostatic pressure within capillary beds. This pressure gradient forces fluid out of the intravascular space and into the interstitial tissues. Oedema develops most readily in gravity-dependent regions, particularly the ankles and lower legs in ambulant individuals, and the sacral area in those who are bedbound.
As venous congestion progresses, fluid accumulation may extend into the peritoneal cavity, producing ascites. Ascites increases intra-abdominal pressure and limits diaphragmatic excursion, which can create a sensation of breathlessness even in the absence of pulmonary congestion. Jugular venous distension reflects elevated right atrial pressure and provides a visible marker of systemic venous hypertension, often correlating closely with central venous pressure.
Neurohormonal Activation and Ventricular Remodelling
Reduced effective cardiac output and renal perfusion trigger compensatory neurohormonal responses. Activation of the renin–angiotensin–aldosterone system promotes sodium and water retention, increasing circulating volume. Sympathetic activation raises heart rate and peripheral vascular tone in an attempt to preserve blood pressure and perfusion. While these mechanisms provide short-term haemodynamic support, they increase venous congestion and place additional volume and pressure load on the failing right ventricle.
Structural remodelling of the right ventricle accompanies these neurohormonal changes. Pressure overload leads to myocardial hypertrophy, while chronic volume overload promotes chamber dilation. Both patterns increase wall stress and reduce mechanical efficiency. As remodelling progresses, the right ventricle becomes less responsive to compensatory mechanisms, creating a self-perpetuating cycle of declining function and worsening systemic congestion.
Clinical Connections
Right-sided heart failure is dominated by features of systemic venous congestion rather than primary pulmonary symptoms. Patients commonly describe progressive ankle and lower limb swelling, increasing abdominal girth from ascites, early satiety and nausea due to gastrointestinal congestion, and profound fatigue related to reduced effective cardiac output. Breathlessness may be present, but it is often secondary to abdominal distension or coexisting lung disease rather than pulmonary oedema. Symptoms typically evolve gradually, which can delay recognition until congestion is advanced.
Clinical examination provides important clues to severity and progression. Typical findings include elevated jugular venous pressure reflecting raised right atrial pressure, pitting peripheral oedema, hepatomegaly with right upper quadrant discomfort, and ascites in more advanced disease. Key patterns that suggest worsening decompensation include:
Rapid weight gain and increasing oedema, indicating fluid accumulation.
Rising jugular venous pressure that does not fall with diuretic therapy, suggesting persistent venous congestion.
Abdominal discomfort or early satiety from worsening hepatic and gastrointestinal congestion.
Management is directed toward relieving congestion, supporting right ventricular function, and addressing the underlying driver. Diuretics are central to reducing venous pressure and improving symptoms, but they must be balanced carefully to avoid excessive preload reduction, which can further impair right ventricular output. When pulmonary hypertension or chronic lung disease contributes, optimisation of respiratory status and pulmonary vascular management is essential. In secondary right-sided failure due to left-sided heart disease, improving left ventricular function and reducing pulmonary pressures can significantly ease right ventricular strain. Ongoing assessment of volume status, renal function, and symptom burden is critical, as right-sided failure often progresses insidiously and may require frequent adjustment of therapy.
Concept Check
Why is the right ventricle particularly vulnerable to increased pulmonary vascular resistance?
How does chronic left-sided heart failure contribute to right-sided heart failure?
Why do patients with right-sided failure develop peripheral oedema?
What causes hepatomegaly in right-sided heart failure?
How does neurohormonal activation contribute to disease progression?